Search the collection

192 results for Anti-CXCR4

Sort by:

Sort by

Limit results to:

20 per page

192 results for Anti-CXCR4

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment
Author / Creator:Wu, Adela ; Maxwell, Russell ; Xia, Yuanxuan ; Cardarelli, Pina ; Oyasu, Miho ; Belcaid, Zineb ; Kim, Eileen ; Hung, Alice ; Luksik, Andrew S. ; Garzon-Muvdi, Tomas ; Jackson, Christopher M. ; Mathios, Dimitrios ; Theodros, Debebe ; Cogswell, John ; Brem, Henry ; Pardoll, Drew M. ; Lim, Michael
Publisher:New York: Springer US
Journal title:Journal of neuro-oncology, 2019-06, Vol.143 (2), p.241-249
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies
Author / Creator:Peng, Sheng-Bin ; Zhang, Xiaoyi ; Paul, Donald ; Kays, Lisa M. ; Ye, Ming ; Vaillancourt, Peter ; Dowless, Michele ; Stancato, Louis F. ; Stewart, Julie ; Uhlik, Mark T. ; Long, Haiyan ; Chu, Shaoyou ; Obungu, Victor H.
Publisher:United States: Public Library of Science
Journal title:PloS one, 2016-03, Vol.11 (3), p.e0150585-e0150585
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
Author / Creator:Kashyap, Manoj K. ; Amaya-Chanaga, Carlos I. ; Kumar, Deepak ; Simmons, Brett ; Huser, Nanni ; Gu, Yin ; Hallin, Max ; Lindquist, Kevin ; Yafawi, Rolla ; Choi, Michael Y. ; Amine, Ale-Ali ; Rassenti, Laura Z. ; Zhang, Cathy ; Liu, Shu-Hui ; Smeal, Tod ; Fantin, Valeria R. ; Kipps, Thomas J. ; Pernasetti, Flavia ; Castro, Januario E.
Publisher:England: BioMed Central
Journal title:Journal of hematology and oncology, 2017-05, Vol.10 (1), p.112-112, Article 112
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Doxorubicin-loaded PEG-CdTe QDs conjugated with anti-CXCR4 mAbs: a novel delivery system for extramedullary multiple myeloma treatment
Author / Creator:Chen, Dangui ; Chen, Fei ; Lu, Jia ; Wang, Lihong ; Yao, Fusheng ; Xu, Haitao
Publisher:New York: Springer US
Journal title:Journal of materials science. Materials in medicine, 2024-01, Vol.35 (1), p.6-11, Article 6
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
Author / Creator:Costa, Maria José ; Kudaravalli, Jyothirmayee ; Ma, Jing-Tyan ; Ho, Wei-Hsien ; Delaria, Kathy ; Holz, Charles ; Stauffer, Angela ; Chunyk, Allison Given ; Zong, Qing ; Blasi, Eileen ; Buetow, Bernard ; Tran, Thomas-Toan ; Lindquist, Kevin ; Dorywalska, Magdalena ; Rajpal, Arvind ; Shelton, David L. ; Strop, Pavel ; Liu, Shu-Hui
Publisher:London: Nature Publishing Group UK
Journal title:Scientific reports, 2019-02, Vol.9 (1), p.2443-2443, Article 2443
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells
Author / Creator:Ottaiano, Alessandro ; di Palma, Antonella ; Napolitano, Maria ; Pisano, Carmen ; Pignata, Sandro ; Tatangelo, Fabiana ; Botti, Gerardo ; Acquaviva, Angela Maria ; Castello, Giuseppe ; Ascierto, Paolo Antonio ; Iaffaioli, Rosario Vincenzo ; Scala, Stefania
Publisher:Berlin: Springer
Journal title:Cancer Immunology, Immunotherapy, 2005-08, Vol.54 (8), p.781-791
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
Author / Creator:Weigold, Florian ; Günther, Jeannine ; Pfeiffenberger, Moritz ; Cabral-Marques, Otavio ; Siegert, Elise ; Dragun, Duska ; Philippe, Aurélie ; Regensburger, Ann-Katrin ; Recke, Andreas ; Yu, Xinhua ; Petersen, Frank ; Catar, Rusan ; Biesen, Robert ; Hiepe, Falk ; Burmester, Gerd R. ; Heidecke, Harald ; Riemekasten, Gabriela
Publisher:England: BioMed Central Ltd
Journal title:Arthritis research & therapy, 2018-03, Vol.20 (1), p.52-52, Article 52
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
399. Transposition of Anti-HIV Transgenes rhTRIM5α, mAPOBEC 3, Anti-CXCR4 and CCR5 siRNAs by Sleeping Beauty (SB) Transposon System for HIV Gene Therapy
Publisher:Elsevier Inc
Journal title:Molecular therapy, 2007-05, Vol.15, p.S153-S153
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
Newsletter articlesFull Text
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "ANTI-CXCR4 ANTIBODIES AND USES THEREOF"
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2025
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
Newsletter articlesFull Text
"Anti-Cxcr4 Antibody Combined With Activated And Expanded Natural Killer Cells For Cancer Immunotherapy" in Patent Application Approval Process (USPTO 20230181635)
Publisher:NewsRX LLC
Journal title:Vaccine Weekly, 2023, p.59
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
Newsletter articlesFull Text
Patent Issued for Treatment Of iC1013G/CXCR4/I-Associated Waldenstrom'S Macroglobulinemia With An anti-CXCR4 Antibody (USPTO 11220548)
Publisher:NewsRX LLC
Journal title:Hematology Week, 2022, p.1015
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
233. Using Recombinant SV40 Vectors To Deliver Antioxidant and Anti-CXCR4 Transgenes To Prevent Neuronal Apoptosis
Publisher:Elsevier Inc
Journal title:Molecular therapy, 2003-05, Vol.7 (5), p.S92-S92
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesFull Text
Jinan University Researchers Further Understanding of Cancer (Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity)
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2021-01, p.2547
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
Newsletter articlesFull Text
State Intellectual Property Office of China Releases Institute Biophysics, CAS's Patent Application for Anti-CXCR4 Single-Domain Antibody, Bispecific Antibody and Drug Conjugate
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
Newsletter articlesFull Text
MSM Protein Technologies Submits Patent Application for Anti-CXCR4 Antibodies
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2019
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
Newsletter articlesFull Text
Pfizer (PFE) issued patent titled "Anti-CXCR4 antibodies and antibody-drug conjugates"
Publisher:Melbourne: News Bites Pty Ltd
Journal title:News Bites - Pharmaceuticals & Biotechnology, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
Newsletter articlesFull Text
Dana-Farber Cancer Institute, Bristol-Myers Squibb Assigned Patent for Treatment of C1013G/CXCR4-Associated Waldenstrom's Macroglobulinemia with Anti-CXCR4 Antibody
Publisher:Washington, D.C: Targeted News Service
Journal title:Targeted News Service, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
Newsletter articlesFull Text
Bristol-Myers Squibb Secures Patent on Treatment of C1013G/CXCR4-Associated Waldenstrom's Macroglobulinemia with an Anti-CXCR4 Antibody
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesFull Text
Researchers at Moores Cancer Center Report Findings in Chronic Lymphocytic Leukemia [Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leu...
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2016-07, p.3746
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesFull Text
Anti‑CXCR4 chemokine receptor, motixafortide, as an adjunct treatment with anti‑TB drugs decreases the bacterial burden by improving drug distribution
Author / Creator:Davuluri, Kusuma ; Singh, Amit ; Singh, Ajay ; Kumar, Vimal ; Singh, Shoor ; Chauhan, Devendra
Journal title:World Academy of Sciences journal, 2023-03, Vol.5 (2), Article 13
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 192 results

Export record to excel

Export this record

Export record to excel

Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment

Export this record

Export record to excel

Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies

Export this record

Export record to excel

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia

Export this record

Export record to excel

Doxorubicin-loaded PEG-CdTe QDs conjugated with anti-CXCR4 mAbs: a novel delivery system for extramedullary multiple myeloma treatment

Export this record

Export record to excel

Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

Export this record

Export record to excel

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

Export this record

Export record to excel

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

Export this record

Export record to excel

399. Transposition of Anti-HIV Transgenes rhTRIM5α, mAPOBEC 3, Anti-CXCR4 and CCR5 siRNAs by Sleeping Beauty (SB) Transposon System for HIV Gene Therapy

Export this record

Export record to excel

INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "ANTI-CXCR4 ANTIBODIES AND USES THEREOF"

Export this record

Export record to excel

"Anti-Cxcr4 Antibody Combined With Activated And Expanded Natural Killer Cells For Cancer Immunotherapy" in Patent Application Approval Process (USPTO 20230181635)

Export this record

Export record to excel

Patent Issued for Treatment Of iC1013G/CXCR4/I-Associated Waldenstrom'S Macroglobulinemia With An anti-CXCR4 Antibody (USPTO 11220548)

Export this record

Export record to excel

233. Using Recombinant SV40 Vectors To Deliver Antioxidant and Anti-CXCR4 Transgenes To Prevent Neuronal Apoptosis

Export this record

Export record to excel

Jinan University Researchers Further Understanding of Cancer (Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity)

Export this record

Export record to excel

State Intellectual Property Office of China Releases Institute Biophysics, CAS's Patent Application for Anti-CXCR4 Single-Domain Antibody, Bispecific Antibody and Drug Conjugate

Export this record

Export record to excel

MSM Protein Technologies Submits Patent Application for Anti-CXCR4 Antibodies

Export this record

Export record to excel

Pfizer (PFE) issued patent titled "Anti-CXCR4 antibodies and antibody-drug conjugates"

Export this record

Export record to excel

Dana-Farber Cancer Institute, Bristol-Myers Squibb Assigned Patent for Treatment of C1013G/CXCR4-Associated Waldenstrom's Macroglobulinemia with Anti-CXCR4 Antibody

Export this record

Export record to excel

Bristol-Myers Squibb Secures Patent on Treatment of C1013G/CXCR4-Associated Waldenstrom's Macroglobulinemia with an Anti-CXCR4 Antibody

Export this record

Export record to excel

Researchers at Moores Cancer Center Report Findings in Chronic Lymphocytic Leukemia [Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leu...

Export this record

Export record to excel

Anti‑CXCR4 chemokine receptor, motixafortide, as an adjunct treatment with anti‑TB drugs decreases the bacterial burden by improving drug distribution

Refine your search